1. A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade. (12th October 2017) Authors: Nuciforo, P; Pascual, T; Cortés, J; Llombart-Cussac, A; Fasani, R; Paré, L; Oliveira, M; Galvan, P; Martínez, N; Bermejo, B; Vidal, M; Pernas, S; López, R; Muñoz, M; Garau, I; Manso, L; Alarcón, J; Martínez, E; Rodrik-Outmezguine, V; Brase, J C Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study). (23rd October 2018) Authors: Pernas, S; Villagrasa, P; Vivancos, A; Scaltriti, M; Rodon, J; Burgues, O; Nuciforo, P G; Canes, J; Dueñas, M; Vidal, M; Lluch, A; Perelló, A; Llombart, A; Dorca, J; Montaño, Á; Oliveira, M; Ribas, G; Rapado, I; Prat, A; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study. (23rd October 2018) Authors: Prat, A; Adamo, B; Perez Fidalgo, J A; Blanch, S; Martinez, N; Gomez Pardo, P; López González, A; Murillo Juso, L; Amillano, K; Vidal, M; Pascual, T; Pare, L; Canes, J; Galvan, P; Gonzalez Farre, B; Ortega Cebrian, V; Gonzalez, X; Bellet Ezquerra, M; Villagrasa, P; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗